Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Philip Rosenfeld

The Power List 2014


Philip Rosenfeld

Philip Rosenfeld, a retina specialist with particular interest in the treatment and study of macular degeneration, has been instrumental in the clinical evaluations and introduction of AMD therapies. These include photodynamic therapy, as well as the introduction into ophthalmology of the VEGF-inhibitors, bevacizumab and ranibizumab.


Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register